Beedan 20 mg Tablet

Beedan 20 mg Tablet contains dasatinib, a targeted anticancer medicine used to treat certain types of blood cancer. Each tablet contains 20 mg of dasatinib and is taken orally as prescribed by a specialist. It is mainly used for Philadelphia chromosome-positive chronic myeloid leukemia and acute lymphoblastic leukemia.

BUY NOW

Dasatinib is a tyrosine kinase inhibitor that blocks BCR-ABL and other abnormal signaling proteins involved in the growth of leukemia cells. By inhibiting these signals, it helps reduce the growth and survival of abnormal blood cells. Treatment is prescribed according to the patient’s leukemia type, clinical condition, and response to therapy. Regular blood tests and medical monitoring are important during treatment to assess response and manage potential adverse effects.

Technical Specification

Specification Details
Active Ingredient Dasatinib
Strength 20 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 60 Tablets
Manufacturer Adley Formulations

Product Also Known As

Beedan 20 mg Tablet, Dasatinib 20 mg Tablet, Beedan Dasatinib Tablet, Dasatinib Anticancer Tablet, Beedan Leukemia Treatment Tablet, Dasatinib Tyrosine Kinase Inhibitor Tablet